Aclaris Therapeutics

Aclaris Therapeutics

A company developing treatments for dermatology and immunology.

All edits by  Liron Shapira 

Edits on 30 April, 2019
Liron Shapira
Liron Shapira approved a suggestion from Golden's AI on 30 April, 2019 9:13 pm
Edits made to:
Article (+8/-8 characters)


Aclaris has two commercialized products in its portfolio, Eskata and Rhofade. Eskata is topical treatment for SKs (seborrheic keratoses). SKs are harmless spots that pop up as a person ages. Rhofade on the other hand, is a topical treatment for persistent facial erythema associated with rosacea in adults. Rhofade was originally developed by AllerganAllergan, which Aclaris then acquired the worldwide rights to.

No more activity to show.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.